Fidelity Investments reports a 2.74% Q1 loss for its Balanced Fund. See how equity picks and bond strategy shaped results. Review the full update.

IBM has released its Q2 2025 results, which showed the company beating analyst expectations. Despite outperforming EPS and revenue predictions, IBM stock still took a hit due to its software business underperforming against expectations.

Key Points - Adjusted earnings per share (Non-GAAP) reached $5.46 for Q2 2025, up 37% year over year and surpassing analyst expectations by 16 %. Revenue (GAAP) climbed 8% year over year to $7.0 billion in Q2 2025,

Intel Corporation's latest Q2 earnings have embedded several bombshell updates to its turnaround strategy. Click here to find out why INTC stock is a Hold.

Stocks That Just Made Investors Richer. Deutsche Bank Aktiengesellschaft (NYSE:DB) is one of the best-performing stocks on Thursday. Deutsche Bank jumped for a fourth straight day on Thursday, adding 7.

Tesla’s battery business has been feeling the pain, too. For a while, this was a growth area for the company, albeit one with a relatively minor contribution to the bottom line. During Q2 2025, Tesla’s energy generation and storage division brought in $2.8 billion in revenue, a 7 percent decline from the same period in 2024.

Asset quality improved in Q2 2025, but a large commercial real estate charge-off drove a rise in net charge-offs for the quarter. These 10 stocks could mint the next wave of millionaires › Tompkins Financial (NYSEMKT:TMP),

Union Pacific Corp. (NYSE: UNP) is showing strong growth in operations and finances, supported by productivity gains and a earnings beat. Analysts raise price forecast and see potential for merger with Norfolk Southern.

The automotive parts supplier reduced its 2025 outlook, as it continues to execute its plan to cut $200 million in costs over two years.

Chevy Colorado sales were flat for 26,959 deliveries in Q2 2025, placing behind the Toyota Tacoma but ahead of Ford Ranger, Nissan Frontier and Jeep Gladiator.

Second-quarter earnings come amid many high-level challenges for the biopharma industry. How will these five closely watched biotechs fare?

American Airlines' financial health is precarious with high leverage, negative working capital, and slim free cash flow, making it vulnerable to sales declines. Learn more on AAL stock here.